SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about press release

06 Aug 2025 Evaluate
Gland Pharma has informed that it enclosed copies of the newspaper advertisement pertaining to Unaudited Financial Results of the Company for the quarter ended June 30, 2025.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1739.10 -16.90 (-0.96%)
16-Apr-2026 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1231.95
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×